How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...

WHEN ANTHROPIC, an artificial-intelligence lab, debuts on stock markets later this year, it is likely to be one of the biggest initial public offerings in history. That’s because the company’s Claude ...

To use this trace, just keep clicking on the ``Make one step'' button. You can use the ``Finish this call'' button to skip to the step after finishing the current level. The call stack in the display ...

Treat an LLM as the step function of a Turing machine. Everything else falls out: state lives on disk, the program is markdown, runs are resumable and observable, and "agents" are just user-authored ...

Abstract: Return-oriented programming (ROP) attacks pose a significant threat to the control-flow integrity (CFI) of Internet of Things (IoT) devices, which operate in resource-constrained ...

Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...